Skip to content
★ Sign in to follow
GW

Geoffrey Wolf

Opiant Pharmaceuticals, Inc.
Total declarations
18
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (8 ops.)
€4.0M

Latest filing published 17 Apr 2018 for Opiant Pharmaceuticals, INC..

Filing timeline

BuySale
Geoffrey Wolf

Insider track record

Disclosed buys
0
Disclosed sells
8
Signal history

Geoffrey Wolf: trading record in brief

Geoffrey Wolf appears in our data through filings on Opiant Pharmaceuticals, Inc. shares, published by SEC (Form 4). We count 18 filings; the first trade dates from 1 December 2017 and the latest from 8 April 2018.

The open-market record consists of 8 sales worth €4.0M, with no purchase. Other entries cover 1 share grant. So far in 2018, the count stands at no purchases and 5 sales.

Most recently, on 17 April 2018, the filings show a transaction in Opiant Pharmaceuticals, Inc. Typically, a trade is published a median of 21 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Geoffrey Wolf

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations17 total

17 of 17 declarations